We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International Convention
June 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag Tech
July 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
Search BIO members.
July 8 - 11, 2019 | Des Moines, Iowa
As DSM’s Chief Innovation Officer, Trish Malarkey shapes DSM’s long-term innovation strategy, accelerating and supporting innovation throughout the company and creating new businesses to deliver DSM’s Purpose-Led, Performance-Driven strategy.
Trish has 30 years of experience in agricultural innovation. With extensive experience in senior R&D Leadership positions in multinational companies like AgrEvo and Syngenta, she has a breadth of technical knowledge across biology, chemistry, and biotechnology.
Trish has successfully executed the delivery of innovation for commercial success, translated business strategies into technology pipelines and most recently as Head of Research & Development at Syngenta, led around 5000 scientific professionals in over 90 countries, recreating the R&D strategy, innovation pipeline, and organizational capabilities. Trish has also acted as a Scientific Advisor for a number of private equity companies and as a Non-Executive Director for Novozymes.
Trish joined DSM in 2019. She is a British and American national, based in Geleen, The Netherlands.
This speaker's sessions: